🇺🇸 FDA

Drug profile · INN

tanezumab

RAYLUMIS

EMA: refused N02
Patents linked
0
News articles
0

Quick answer

tanezumab (RAYLUMIS) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tanezumab
Brand RAYLUMIS
ATC code N02

Frequently asked questions

What is tanezumab?

tanezumab (RAYLUMIS) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for tanezumab?

RAYLUMIS is a marketed brand name for tanezumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.